Blog - Medical And Dental Instruments

Australia Sees a 14% Increase in Medical Furniture Imports, Reaching $152 Million in 2024

Feb 8, 2025

Medical Furniture imports peaked at 8.4M units in 2015, but decreased in the following years. By 2024, the value of imports notably dropped to $124M.

Zimmer Biomet Projects Lower 2025 Profit Due to Currency Challenges

Feb 6, 2025

Zimmer Biomet faces currency challenges, projecting lower 2025 profits. Despite exceeding Q4 sales expectations, future earnings are anticipated to be below Wall Street forecasts.

Bausch + Lomb Retains Public Status Amidst Separation Plans from Parent Company

Feb 6, 2025

Bausch + Lomb decides to maintain its public status as separation plans from its parent company unfold, focusing on strengthening its market presence in Canada.

CONMED Reports Strong Q4 2024 Revenue, Surpassing Wall Street Expectations

Feb 6, 2025

CONMED's Q4 2024 revenue surpassed expectations with a 5.8% rise, though full-year forecasts fell short. Despite stock setbacks, EPS growth suggests long-term potential for investors.

Align Technology Meets Q4 Revenue Expectations Amid Mixed Future Outlook

Feb 6, 2025

Align Technology matches Q4 revenue expectations but predicts revenue shortfalls, reflecting challenges in the dental fittings market.

Envista Holdings Reports Strong Q4 Performance with Revenue Growth

Feb 6, 2025

Envista Holdings surpasses Q4 2024 revenue forecasts with a 1.1% sales increase, despite challenges in the dental sector. The company outperforms EPS estimates, showcasing potential for future growth.

STERIS Falls Short of Market Expectations Despite Revenue Growth

Feb 6, 2025

STERIS reports a 5.6% increase in Q4 sales, reaching $1.37 billion, missing market expectations despite stable industry demand and consistent operational efficiency.

Siemens Healthineers Exceeds Q1 Revenue Expectations

Feb 6, 2025

131

Siemens Healthineers surpasses Q1 revenue expectations with notable U.S. sales growth, poised for continued success despite regional challenges.

Thermo Fisher Surpasses Expectations with Robust Q4 Performance

Jan 30, 2025

154

Thermo Fisher Scientific outperforms Q4 expectations with a 5% revenue increase, showcasing strong demand in therapy development.

Grail's Meteoric Stock Surge Amidst Cancer Screening Innovations

Jan 27, 2025

434

Grail's shares recently jumped 64% thanks to advancements in cancer detection and supportive AI initiatives, attracting significant market interest.

Intuitive Surgical's Robust Earnings Surpass Expectations

Jan 24, 2025

194

Intuitive Surgical surpasses Q4 earnings expectations with strong sales of da Vinci surgical robots, marking a 25% revenue growth.

Hong Kong Experiences 38% Surge in Spectacle Glass Lenses Exports, Reaching An Unprecedented $348 Million in 2024

Jan 22, 2025

The Spectacle Glass Lenses exports peaked at 83M units in 2017, but from 2018 to 2024, they slightly decreased. In terms of value, the exports reduced to $306M in 2024.